Recent research uncovers the role of the gene TEAD1 in the tissue changes driving diabetic erectile dysfunction, revealing new possibilities for targeted therapies beyond blood sugar control.
New research suggests that a gene called TEAD1 may help drive the tissue changes behind diabetic erectile dysfunction, a common complication in men with diabetes. In a rat model, investigators reported that blocking TEAD1 improved erectile function and appeared to shift smooth muscle cells in the penis away from a damaged, less functional state. The findings add to a wider body of work showing that diabetic erectile dysfunction is not caused by blood sugar alone, but by a mix of vascular injury, cell death and structural change in penile tissue.
In the study, researchers induced diabetes in rats using streptozotocin and then assessed erectile response with electrical stimulation and an apomorphine test. They found that knocking down TEAD1 with CRISPR/Cas9 improved the intracavernosal pressure response, a standard measure of erection quality, and eased tissue damage seen on staining tests. The team also isolated corpus cavernosum smooth muscle cells and found that TEAD1 suppression increased cell survival while reducing apoptosis, the process of programmed cell death.
The study sits alongside other recent work pointing to several pathways in diabetic erectile dysfunction. A separate review published in Frontiers in Endocrinology found that age, diabetes duration, poor glucose control and other illnesses raise the risk of erectile dysfunction in men with diabetes. Another review has highlighted endothelial and smooth muscle cell death as central to the condition, while a 2025 report on endothelin-1 linked high blood sugar to vascular injury that can undermine erectile function. Work on YAP, a related signalling protein, has also suggested that abnormal cell transition in penile tissue may worsen the disorder.
The TEAD1 study went further by linking the gene to calcium signalling, a pathway essential for smooth muscle contraction. According to the researchers, TEAD1 knockdown altered calcium-related proteins and increased intracellular calcium levels, while the calcium channel blocker nimodipine reversed the benefit seen in the animals and their cells. That pattern suggests TEAD1 may influence erectile function by helping determine whether corpus cavernosum smooth muscle cells remain contractile, which is the state needed for normal erection, or shift into a synthetic form associated with dysfunction. The authors said the findings warrant more study, but the work adds another possible target for future treatments.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
